Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

786 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 172
Recruiting: 93
Ph III recruiting: 9
Growth YoY: +32.4%
Industry share: 20%
Top sponsor: Ruijin Hospital
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (129)

clinicaltrialsPublishedShowing 51–100 of 109 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07535710	Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma	not yet recruiting	Phase 1 / Phase 2	37	Shanghai Jiao Tong University School of MedicineOTHER	1	Apr 17, 2026	clinicaltrials
NCT07535762	Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma	not yet recruiting	Phase 2	36	Shanghai Jiao Tong University School of MedicineOTHER